Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAX E MERCADO

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1336151182
CMS profile
151365
Location
PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$12,838.54

231 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 5; records 51–100 of 231 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAX E MERCADO

NPI 1336151182 · CMS profile ID 151365

Allopathic & Osteopathic Physicians / Internal Medicine

PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 231 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336151182?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAX E MERCADO, NPI 1336151182, CMS profile ID 151365. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 231 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336151182?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MAX E MERCADO, NPI 1336151182, CMS profile ID 151365. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 231 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336151182?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MAX E MERCADO, NPI 1336151182, CMS profile ID 151365, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 231 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1336151182?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

231 matching records · $12,838.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 231 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 231.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $19.5609/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018819945 CMS
Amgen Inc. $19.9809/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020636089 CMS
Novo Nordisk Inc $5.1809/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311719 CMS
Ironwood Pharmaceuticals, Inc $17.7109/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045590769 CMS
ABBVIE INC. $19.5609/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904643 CMS
ABBVIE INC. $10.8909/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904641 CMS
GlaxoSmithKline, LLC. $9.8509/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001431365 CMS
Otsuka America Pharmaceutical, Inc. $19.0709/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014580007 CMS
Amgen Inc. $5.2309/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020636087 CMS
AstraZeneca Pharmaceuticals LP $16.7509/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015052815 CMS
Exact Sciences Corporation $20.2909/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026609523 CMS
Novo Nordisk Inc $21.9209/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311853 CMS
IDORSIA PHARMACEUTICALS US INC $20.9109/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034372281 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1.2409/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057125585 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $7.4809/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057217193 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $5.5009/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057496095 CMS
AstraZeneca Pharmaceuticals LP $16.3908/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016171229 CMS
Lilly USA, LLC $20.1108/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031798649 CMS
Lilly USA, LLC $26.2208/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031818445 CMS
ABBVIE INC. $3.7508/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904639 CMS
ABBVIE INC. $14.2308/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904637 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1.2808/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057218621 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.8408/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057291507 CMS
GlaxoSmithKline, LLC. $14.3208/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001430939 CMS
Novo Nordisk Inc $10.3308/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311751 CMS
ABBVIE INC. $18.5008/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904635 CMS
AstraZeneca Pharmaceuticals LP $17.5008/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015791151 CMS
Esperion Therapeutics, Inc. $14.8208/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050743169 CMS
Lundbeck LLC $19.1508/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032289877 CMS
Amgen Inc. $4.4308/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020636085 CMS
Novartis Pharmaceuticals Corporation $15.4108/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992734533 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.4208/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057417207 CMS
GlaxoSmithKline, LLC. $1.2708/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001431455 CMS
GlaxoSmithKline, LLC. $14.2608/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001431501 CMS
Lilly USA, LLC $9.9108/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031891513 CMS
Novo Nordisk Inc $5.4508/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311729 CMS
ABBVIE INC. $10.6808/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904633 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.3808/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057206663 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.0908/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994847 CMS
Amgen Inc. $2.9507/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020636083 CMS
Novo Nordisk Inc $15.7707/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311795 CMS
Exact Sciences Corporation $20.9407/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026609507 CMS
GlaxoSmithKline, LLC. $12.9407/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001431295 CMS
GlaxoSmithKline, LLC. $3.8107/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001431435 CMS
Novo Nordisk Inc $13.8707/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001311773 CMS
ABBVIE INC. $14.0407/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997904631 CMS
Merck Sharp & Dohme LLC $13.9607/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048483447 CMS
Lilly USA, LLC $20.1107/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031818435 CMS
Lilly USA, LLC $1.9707/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031865415 CMS
Lilly USA, LLC $1.6407/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031914815 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,611.61 242
PY2020 $6,274.46 198
PY2021 $13,338.80 246
PY2022 $4,567.95 224
PY2023 $12,838.54 231
PY2024 $5,235.78 194
PY2025 $3,103.67 180

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $76,552.22 31
PY2024 Principal investigator $141,523.89 39
PY2023 Principal investigator $294,841.60 32

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Currax Pharmaceuticals LLC $558.90 12/04/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242717031
Principal investigator 1 Currax Pharmaceuticals LLC $800.00 10/14/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716983
Principal investigator 1 Genentech, Inc. $22.00 09/26/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589929
Principal investigator 1 Genentech, Inc. $3,800.00 09/24/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589925
Principal investigator 1 Exact Sciences Corporation $4,500.00 08/29/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037491
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,000.00 07/16/2025 Non-covered Recipient Entity
MERCADO MEDICAL PRACTICE
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older No dispute reported 06/30/2026 1185555585
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,500.00 07/01/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190311171
Principal investigator 1 Novartis Pharmaceuticals Corporation $59.93 06/30/2025 Non-covered Recipient Entity
CCT RESEARCH
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190312591
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,745.00 06/27/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 No dispute reported 06/30/2026 1185555587
Principal investigator 1 Currax Pharmaceuticals LLC $1,654.62 06/24/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716979
Principal investigator 1 Currax Pharmaceuticals LLC $276.00 06/19/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716911
Principal investigator 1 Currax Pharmaceuticals LLC $1,324.80 05/28/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716907
Principal investigator 1 Currax Pharmaceuticals LLC $5,727.69 04/24/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716947
Principal investigator 1 Currax Pharmaceuticals LLC $2,639.00 04/04/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716905
Principal investigator 1 Currax Pharmaceuticals LLC $3,310.62 03/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716857
Principal investigator 1 Currax Pharmaceuticals LLC $372.60 03/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716863
Principal investigator 1 Genentech, Inc. $324.00 03/26/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589126
Principal investigator 1 Genentech, Inc. $86.00 03/21/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589065
Principal investigator 1 Genentech, Inc. $200.00 03/05/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589082
Principal investigator 1 Currax Pharmaceuticals LLC $750.00 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716765
Principal investigator 1 Currax Pharmaceuticals LLC $331.20 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716771
Principal investigator 1 Currax Pharmaceuticals LLC $186.30 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716781
Principal investigator 1 Currax Pharmaceuticals LLC $8,580.54 02/20/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716833
Principal investigator 1 Exact Sciences Corporation $1,000.00 01/31/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037487
Principal investigator 1 Genentech, Inc. $750.00 01/29/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589231
Principal investigator 1 Genentech, Inc. $527.00 01/14/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589146
Principal investigator 1 Genentech, Inc. $527.00 01/13/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589336
Principal investigator 1 AstraZeneca Pharmaceuticals LP $22,390.00 01/08/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 No dispute reported 06/30/2026 1185555591
Principal investigator 1 ModernaTX, Inc. $1,272.52 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964130
Principal investigator 1 ModernaTX, Inc. $621.00 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964132
Principal investigator 1 ModernaTX, Inc. $715.50 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964134